Target intelligence / Profile preview

RNA, 7SK small nuclear pseudogene 262 (RN7SKP262)

Target
RN7SKP262
Molecular classification
Other (Pseudogene; not a receptor, enzyme, transporter, etc.)
01

Overview

RN7SK pseudogene 262 (RN7SKP262) is a pseudogene (non-protein-coding genetic element) related to the 7SK small nuclear RNA (RN7SK) gene family[4]. Unlike RN7SK, which encodes a regulatory small nuclear RNA with well-established roles in transcriptional regulation, the RN7SKP262 pseudogene does not encode a functional RNA or protein product and is not known to have any biological activity or be a therapeutic target[4]. The functional RN7SK gene produces a small nuclear RNA that participates in the regulation of transcription elongation by sequestering the P-TEFb complex (CDK9/Cyclin T), but RN7SKP262 is simply a non-functional genomic remnant and is not listed as playing a functional role in transcription or disease[1][2][3][4][5]. Pseudogenes are generally not involved in signal transduction, cell cycle, or other canonical functions and are not targeted by drugs and do not serve as biomarkers. RN7SKP262 does not code for a functional RNA or protein, is not a therapeutic target, and contains no described functional or disease roles. If a therapeutic or biological function is required, the correct target would be the functional parent gene RN7SK, not this pseudogene. If this query was intended to retrieve information about an active target, RN7SKP262 is not the correct entity[4].

Other names
RN7SK pseudogene 262RNA, 7SK small nuclear pseudogene 262RN7SKP262

Beyond the preview

Go deeper on RNA, 7SK small nuclear pseudogene 262 (RN7SKP262).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SK small nuclear pseudogene 262 (RN7SKP262).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call